| 10:30 – 12:30 |
6151: Plenary Session VI: Controversies in Movement Disorders
Chair: C. Warren Olanow, New York, NY, USA
Chair: Eduardo Tolosa, Barcelona, Spain
| 10:30 |
EMBR: Help or hindrance to clinical management? Help
Cristina Sampaio, Lisboa, Portugal
|
| 10:45 |
EBMR: Help or hindrance to clinical management? Hindrance
William Weiner, Baltimore, MD, USA |
| 11:00 |
DBS for Parkinson's disease will be passe in 5 years: Yes
Stanley Fahn, New York, NY, USA
|
| 11:15 |
DBS for Parkinson's disease will be passe in 5 years: No
Paul Krack, Grenoble, France
|
| 11:30 |
Is sporadic Parkinson's disease a genetic disorder? Yes
Vincenzo Bonifati, Rotterdam, Netherlands
|
| 11:45 |
Is sporadic Parkinson's disease a genetic disorder: No
J. William Langston, Sunnyvale, CA, USA |
| 12:00 |
Essential tremor: Multi-system disorder? Yes
Elan D. Louis, New York, NY, USA
|
| 12:15 |
Essential tremor: Multi-system disorder? No
Guenther Deuschl, Kiel, Germany
|
Return to Top
|
| 14:30 – 16:30 |
Parallel Sessions
6201: Update on molecular pathogenesis and protein interactions in Parkinson’s disease
Chair: Un Jung Kang, Chicago, IL, USA
Chair: Leonidas Stefanis, Papagou, Greece
| 14:30 |
Alpha-Synuclein - Molecular pathogenesis
Leonidas Stefanis, Papagou, Greece
|
| 15:00 |
Normal and pathological function of LRRK2
Takeshi Iwatsubo, Tokyo, Japan
|
| 15:30 |
Update on PINK1 biology
Ming Guo, Los Angeles, CA, USA
|
| 16:00 |
Panel discussion
|
6202: Update on DBS for Parkinson’s disease and dystonia
Chair: Joachim K. Krauss, Hannover, Germany
Chair: Pierre Pollak, Grenoble, France
| 14:30 |
STN vs. GPi
Michael S. Okun, Gainesville, FL, USA
|
| 15:00 |
Pednuculopontine nucleus DBS for the treatment of gait problems in Parkinson’s disease
Elena Moro, Toronto, ON, Canada
|
| 15:30 |
DBS in primary and secondary dystonia
Joachim K. Krauss, Hannover, Germany
|
| 16:00 |
Panel discussion
|
6203: Electrical oscillatory correlates of parkinsonism
Chair: John C. Rothwell, London, United Kingdom
Chair: Hagai Bergman, Jerusalem, Israel
| 14:30 |
Link between akinesia and abnormal cortical electrical oscillation
Hagai Bergman, Jerusalem, Israel
|
| 15:00 |
Is rigidity related to slow variations of electrical oscillation in the basal ganglia?
Peter Brown, London, United Kingdom
|
| 15:30 |
Tremor and dysfunction of the cortico-basal ganglia electrical network
Jens Volkmann, Kiel, Germany
|
| 16:00 |
Panel discussion
|
6204: Teaching Course: PSP and CBD
Chair: Oscar S. Gershanik, Buenos Aires, Argentina
Chair: Lawrence I. Golbe, New Brunswick, NJ, USA
| 14:30 |
Clinical diagnosis and differential diagnosis of PSP and CBD
Lawrence I. Golbe, New Brunswick, NJ, USA
|
| 15:00 |
Pathology and role of genetics
Dennis W. Dickson, Jacksonville, FL, USA
|
| 15:30 |
Therapeutic interventions: Current and future
Irene Litvan, Louisville, KY, USA
|
| 16:00 |
Panel discussion
|
6206: Hot topics in Experimental Therpeutics for Parkinson’s disease
Chair: Shinichi Muramatsu, Shimotsuke, Japan
Chair: Clive N. Svendson, Madison, WI, USA
| 14:30 |
Gene Therapy
Jeffrey H. Kordower, Chicago, IL, USA |
| 15:00 |
Cell based therapies
Olle Lindvall, Lund, Sweden |
| 15:30 |
Infusion therapies
Werner Poewe, Innsbruck, Austria
|
| 16:00 |
Panel discussion
|
6207: Teaching Course: Impulse control disorders
Chair: Andrew H. Evans, North Fitzroy, Australia
Chair: Mark A. Stacy, Durham, NC, USA
| 14:30 |
Clinical spectrum (relationship/differences between ICDs and DDS); Relationship to addiction
Andrew H. Evans, North Fitzroy, Australia
|
| 15:00 |
Pathogenesis: Anatomy, role of dopamine, genetic factors, imaging
Antonio P. Strafella, Toronto, ON, Canada
|
| 15:30 |
Assessment, clinical pharmacology, and management
Daniel Weintraub, Philadelphia, PA, USA
|
| 16:00 |
Panel discussion
|
Return to Top |
